Does nitric oxide contribute to the negative chronotropic and inotropic effects of endothelin-1 in the heart?

European Journal of Pharmacology

Volumn 332, Issue 2, 1997, Pages 195-199

  Zhu, Yi ^a,b   Yang, Huang Tian ^a   Endoh, Masao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

cAMP; Endothelin 1; Nitric oxide (NO)

Indexed keywords

CYCLIC AMP; ENDOTHELIN 1; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRAZOSIN;

ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; DRUG EFFECT; HEART MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; DEPRESSION, CHEMICAL; DOGS; ENDOTHELIN-1; HEART; HEART ATRIA; HEART RATE; HEART VENTRICLES; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS;

EID: 0030845043     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01087-X     Document Type: Article

References (23)

1. Balligand, J.L., Kelly, R.A., Marsden, P.A., Smith, T.W., Michel, T., 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90, 347-351.
2. Brady, A.J.B., Warren, J.B., Poole-Wilson, P.A., Williams, T.J., Harding, S.E., 1993. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 256, H176-H182.
3. Brady, A.J.B., Poole-Wilson, P.A., Harding, S.E., Warren, J.B., 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263, H1963-H1966.
4. Han, X., Shimoni, Y., Giles, W.R., 1994. An obligatory role for nitric oxide in autonomie control of mammalian heart rate. J. Physiol. (London) 476, 309-314.
5. Haynes, W.G., Webb, D.J., 1993. The endothelin family of peptides: local hormones with diverse role in health and disease?. Clin. Sci. 84, 485-500.
6. Ishikawa, T., Yanagisawa, M., Kimura, S., Goto, K., Masaki, T., 1988. Positive chronotropic effects of endothelin, a novel endothelium-derived vasocontrictor peptide. Pflüg. Arch. 413, 108-110.
7. James, A.F., Xie, L.H., Fujitani, Y., Hayashi, S., Horie, M., 1994. Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1. Nature 370, 297-300.
8. 2+ ions. J. Card. Failure 1, 143-153.
9. Kitayoshi, T., Watanabe, T., Shimamoto, N., 1989. Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo. Eur. J. Pharmacol. 166, 519-522.
10. Mebazaa, A., Mayoux, E., Maedd, K., Martin, L.D., Lakatta, E.G., Robotham, J.L., Shah, A.M., 1993. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am. J. Physiol. 265, H1841-H1846.
11. Moravec, C.S., Reynolds, E.E., Stewart, R.W., Bond, M., 1989. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 159, 14-18.
12. Nawrath, H., Baumner, D., Rupp, J., Oelert, H., 1995. The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br. J. Pharmacol. 116, 3061-3067.
13. Ono, K., Tsujimoto, G., Sakamoto, A., Eto, K., Masaki, T., Ozaki, Y., Satake, M., 1994. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370, 301-304.
14. A receptors in guinea pig atria. Circ. Res. 76, 284-292.
15. Reid, J.J., Lieu, A.T., Rand, M.J., 1991. Interactions between endothelin-1 and other chronotropic agents in rat isolated atria. Eur. J. Pharmacol. 194, 173-181.
16. Rubanyi, G.M., Polokoff, M.A., 1994. Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol. Rev. 46, 325-415.
17. Sakai, S., Myauchi, T., Kobayashi, M., Yamaguchi, I., Goto, K., Sugishita, Y., 1996. Inhibition of myocaridal endothelin pathway improves long-term survival in heart failure. Nature 384, 353-355.
18. Seki, T., Hagiwara, H., Naruse, K., Kadowaki, M., Kashiwagi, M., Demura, H., Hirose, S., Naruse, M., 1996. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem. Biophys. Res. Commun. 218, 601-605.
19. Takanashi, M., Endoh, M., 1991. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am. J. Physiol. 261, H611-H619.
20. Takanashi, M., Endoh, M., 1992. Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium. J. Pharmacol. Exp. Ther. 262, 1189-1194.
21. Watanabe, T., Kusumoto, K., Kitayoshi, T., Shimamoto, N., 1989. Positive inotropic and vasoconstrictive effects of endothelin-1 in vivo and in vitro experiments: Characteristics and the role of L-type calcium channels. J. Cardiovasc. Pharmacol. 13 (Suppl. 5), S108-S111.
22. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T., 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.
23. Yang, H.-T., Zhu, Y., Endoh, M., 1997. Species-dependent differences in inotropic effects and phosphoinositide hydrolysis induced by endothelin-3 in mammalian ventricular myocardium. Br. J. Pharmacol. 120, 1497-1504.